Ascendis Pharma A/S (ASND) Social Stream



Ascendis Pharma A/S (ASND): $151.17

2.73 (+1.84%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add ASND to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#86 of 363

in industry

ASCENDIS PHARMA A (ASND) Price Targets From Analysts

Use the tables below to see what analysts covering ASCENDIS PHARMA A think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-11 8 $216 $169 $195.222 $137.1 42.39%
2021-11-15 8 $216 $169 $196.666 $137.1 43.45%
2021-11-18 9 $216 $169 $196.666 $137.1 43.45%
2021-11-22 9 $216 $169 $195.888 $137.1 42.88%
2021-12-08 10 $214 $169 $191.444 $137.1 39.64%
2022-01-07 10 $214 $136 $185.9 $137.1 35.59%
2022-01-13 10 $214 $136 $185.4 $137.1 35.23%
2022-01-25 10 $214 $136 $185.7 $137.1 35.45%
2022-01-26 10 $214 $136 $185.5 $137.1 35.3%
2022-02-14 10 $214 $136 $184.09 $137.1 34.27%
2022-02-23 10 $214 $128 $178.545 $137.1 30.23%
2022-03-01 11 $214 $128 $179.25 $137.1 30.74%
2022-03-09 11 $214 $117 $175 $137.1 27.64%
2022-03-15 10 $230 $117 $177.666 $137.1 29.59%
2022-03-22 10 $230 $117 $179.083 $137.1 30.62%
2022-03-28 10 $230 $136 $182.916 $137.1 33.42%
2022-03-29 10 $230 $136 $182.666 $137.1 33.24%
2022-04-13 10 $230.001 $136 $182.666 $137.1 33.24%
2022-04-20 10 $230.001 $136 $182.333 $137.1 32.99%
2022-05-11 10 $230.001 $136 $180.75 $137.1 31.84%
2022-05-12 10 $210 $127 $170.75 $137.1 24.54%
2022-05-13 10 $196 $84 $152.818 $137.1 11.46%
2022-05-31 10 $180 $84 $148.5 $137.1 8.32%
2022-07-25 10 $180 $84 $148 $137.1 7.95%
2022-08-13 10 $184 $84 $146.3 $137.1 6.71%
2022-08-30 11 $184 $84 $148.09 $137.1 8.02%
2022-09-17 11 $176 $84 $144.5 $137.1 5.4%
2022-10-12 11 $172 $84 $144.1 $137.1 5.11%
2022-10-21 12 $172 $84 $144.3 $137.1 5.25%
2022-10-27 12 $182 $84 $147.727 $137.1 7.75%
2022-10-31 12 $182 $84 $149.272 $137.1 8.88%
2022-11-03 12 $182 $84 $150.272 $137.1 9.61%
2022-11-04 12 $182 $93.2 $151.563 $137.1 10.55%
2022-11-14 12 $182 $93.2 $152.472 $137.1 11.21%
2022-11-16 12 $182 $93.2 $150.654 $137.1 9.89%
2022-11-17 12 $182 $93.2 $151.29 $137.1 10.35%
2023-01-13 12 $182 $93.2 $152.018 $137.1 10.88%
2023-01-17 12 $182 $93.2 $153.381 $137.1 11.88%
2023-01-26 12 $182 $104.31 $154.573 $137.1 12.74%
2023-02-16 12 $182 $104.31 $154.937 $137.1 13.01%
2023-02-17 12 $182 $110 $155 $137.1 13.06%
2023-02-21 12 $182 $117.26 $155.932 $137.1 13.74%
2023-03-06 12 $182 $117.26 $156.114 $137.1 13.87%
2023-04-03 12 $195 $117.26 $158.75 $137.1 15.79%
2023-04-04 12 $195 $92 $155.114 $137.1 13.14%
2023-04-10 12 $195 $92 $149.226 $137.1 8.84%
2023-04-24 12 $195 $92 $147.426 $137.1 7.53%
2023-04-27 12 $195 $92 $143.426 $137.1 4.61%
2023-04-28 12 $195 $92 $142.226 $137.1 3.74%
2023-05-01 12 $195 $92 $141.7 $137.1 3.36%
2023-05-02 12 $195 $92 $138.2 $137.1 0.8%
2023-05-08 12 $186 $92 $137.3 $137.1 0.15%
2023-05-10 12 $186 $105 $138.8 $137.1 1.24%
2023-06-07 12 $187 $105 $138.9 $137.1 1.31%
2023-07-31 11 $187 $105 $139.888 $137.1 2.03%
2023-09-06 11 $187 $105 $136.625 $137.1 -0.35%
2023-09-07 11 $192 $110 $135.25 $137.1 -1.35%
2023-10-17 11 $192 $110 $135.5 $137.1 -1.17%
2023-11-08 12 $192 $110 $136 $137.1 -0.8%
2023-11-09 12 $192 $110 $136.666 $137.1 -0.32%
2023-11-20 12 $192 $110 $137.666 $137.1 0.41%
2023-12-12 12 $200 $110 $138.555 $137.1 1.06%
2023-12-20 13 $202 $116 $146.4 $137.1 6.78%

The Trend in the Analyst Price Target


ASND's average price target has moved down $21.65 over the prior 43 months.

ASND reports an average of 54.46% for its upside potential over the past 49 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-04-10 12 195 92 149.226 73.92 101.88%
2023-04-24 12 195 92 143.426 79.77 79.8%
2023-04-27 12 195 92 143.426 76.98 86.32%
2023-06-07 11 187 105 139.888 90.40 54.74%
2023-06-07 12 187 105 138.900 90.40 53.65%

ASND Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.46 10 0 3 0 0 13

The Trend in the Broker Recommendations


Over the past 31 weeks, ASND's average broker recommendation rating improved by 0.04.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ASND as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, ASCENDIS PHARMA A's average analyst price target is greater than 6861.73% of them.
  • In terms of how ASCENDIS PHARMA A fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is greater than 6341.38% of that group.
  • ASND has a higher upside potential (average analyst target price relative to current price) than 1814.92% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, ASCENDIS PHARMA A's variance in analysts' estimates is lower than -4943.67% of them.

Stocks similar to ASCENDIS PHARMA A in the Pharmaceutical Products industry regarding analyst recommendations and price targets are RVNC, TBPH, and PRTA.

Is ASND a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!